Here, we investigated the biological function of METTL3/m6A in regulating ncRNA and defined a novel pathway for m6A-dependent primary microRNA (miRNA) maturation and AKT/mTOR activation in gastric cancer, which could be counteracted by everolimus. The gene discussed is METTL3; the disease is gastric cancer.